SELLAS Life Sciences Group, Inc. (SLS) Tops Q2 EPS by 5c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Ennis (EBF) Reports In-Line Q1 EPS